FCM
IDIX

Farallon Capital Management’s IDENIX PHARMACEUTICALS INC IDIX Stock Holding History

Farallon Capital Management’s Portfolio IDIX Stock Details IDIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-840,000
Closed -$20.2M – 112
2014
Q2 		$20.2M Buy
+840,000
New +$8.76M 0.29% 57

Farallon Capital Management's IDIX Position: Q3 2014 in Review

Farallon Capital Management sold out of IDENIX PHARMACEUTICALS INC (IDIX) in Q3 2014, closing a stake of 840,000 shares — an estimated $20.2M sold.

Farallon Capital Management first reported a position in IDIX in Q2 2014 and held it in 1 quarter. The position peaked at $20.2M in Q2 2014. 0 funds tracked by Wall St. Rank hold IDIX as of Q3 2014.

  • Farallon Capital Management reported no remaining IDENIX PHARMACEUTICALS INC position as of Q3 2014 after selling out during the quarter.
  • Farallon Capital Management sold 840,000 IDENIX PHARMACEUTICALS INC shares in Q3 2014, an estimated $20.2M.
  • Farallon Capital Management first reported a position in IDENIX PHARMACEUTICALS INC in Q2 2014 and held it in 1 quarter.
  • Farallon Capital Management's IDENIX PHARMACEUTICALS INC position peaked at $20.2M in Q2 2014.
  • 0 funds tracked by Wall St. Rank held IDENIX PHARMACEUTICALS INC as of Q3 2014.

Based on Farallon Capital Management's 13F filing for Q3 2014, filed 14 Nov 2014.